Anavex Life Sciences

Filed a patent for "therapy selection and treatment of neurodegenerative disorders" on Fri, July 29, 2022

Filed a patent for "compositions and methods for prevention of cognitive decline caused by degenerative diseases" on Fri, July 29, 2022

Filed a patent for "neurodevelopmental disorder therapy" on Thu, December 8, 2022

Filed a patent for "a2-73 crystalline polymorph compositions of matter and methods of use thereof" on Thu, May 11, 2023

Filed a patent for "sigma-1 receptor agonist systolic blood pressure therapy" on Thu, March 9, 2023

Filed a patent for "a19-144, a2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy" on Thu, September 28, 2023

Filed a patent for "therapy selection and treatment of neurodegenerative disorders" on Mon, June 26, 2023

Filed a patent for "a2-73 as a therapeutic for insomnia, anxiety and agitation" on Thu, February 8, 2024

Filed a patent for "neurodevelopmental disorder therapy" on Thu, February 29, 2024

Filed a patent for "analgesic therapeutic and method, 1-(3-4(((1r,3s,5s)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof" on Thu, May 16, 2024